Table 1. The clinicopathologic characteristics of the ovarian cancer patients, benign ovarian tumor patients and healthy controls.
| Paraffin tumor tissues | Fresh tumor tissues | Peripheral blood | |||||
|---|---|---|---|---|---|---|---|
| OC | BOT | OC | BOT | OC | BOT | HC | |
| Number | 41 | 12 | 14 | 12 | 31 | 26 | 20 |
| Age ± SDa (y) | 51.67 ± 11.71 | 48.64 ± 13.47 | 46.28 ± 15.84 | 55.79 ± 9.99 | 51.2 ± 11.50 | 47.21 ± 18.53 | 48.19 ± 16.74 |
| Stage (n)b | |||||||
| I/II | 18 | 3 | 7 | ||||
| III/IV | 23 | 11 | 24 | ||||
| Histology (n) | |||||||
| Serous | 30 | 7 | 21 | ||||
| Mucinous | 4 | 3 | 4 | ||||
| Othersc | 7 | 4 | 6 | ||||
Abbreviations: OC, ovarian cancer; BOT, benign ovarian tumor; HC, healthy controls.
a
Age at diagnosis.
b
According to the International Federation of Gynecology and Obstetrics.
c
Including endometrioid adenocarcinoma and transitional cell carcinoma.